Acurx Pharmaceuticals, Inc. · NASDAQ:ACXP
Acurx Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 19 institutions reported holding Acurx Pharmaceuticals, Inc., 2.4% of its shares. Largest: Vanguard, Geode Capital and Jane Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Acurx Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 47,304 | 0.90% | no change | Aug 13, 2026 |
| Geode Capital | 26,411 | 0.50% | +1,592 | Aug 12, 2026 |
| Jane Street | 15,727 | 0.30% | −38,915 | Aug 14, 2026 |
| Prospect Financial Services LLC | 13,785 | 0.26% | no change | Aug 6, 2026 |
| Morgan Stanley | 7,500 | 0.14% | +1,000 | Aug 13, 2026 |
| Integrated Wealth Concepts LLC | 4,729 | 0.09% | new | Aug 12, 2026 |
| Tower Research Capital LLC (TRC) | 2,744 | 0.05% | +1,713 | Aug 11, 2026 |
| Wells Fargo | 2,300 | 0.04% | no change | Aug 14, 2026 |
| Westside Investment Management, Inc. | 1,650 | 0.03% | no change | Jul 27, 2026 |
| Lanark Financial, Inc. | 1,500 | 0.03% | no change | Jul 21, 2026 |